AGÕæÈ˹ٷ½

STOCK TITAN

Kimball Electronics Reports Q3 Results and Reiterates Guidance for Fiscal 2025 With Sales and Operating Income Expected at High-End of Range; Company Adds New Facility to Support Strategy to Drive Growth in the Medical CMO

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags

Third Quarter Fiscal 2025 Highlights

  • Net sales totaled $374.6 million
  • Operating income of $11.7 million, or 3.1% of net sales, adjusted operating income of 4.2%
  • Inventory of $296.6 million, a reduction of $9.6 million from Q2
  • Cash generated by operating activities of $30.9 million, the fifth consecutive quarter of positive cash flow
  • Borrowings on credit facilities of $178.8 million, a $26.2 million decrease from the second quarter, and down $116 million, or 40%, in the fiscal year

JASPER, Ind.--(BUSINESS WIRE)-- Kimball Electronics, Inc. (Nasdaq: KE) today announced financial results for the third quarter ended March 31, 2025.

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Three Months Ended

Ìý

Nine Months Ended

Ìý

March 31,

Ìý

March 31,

(Amounts in Thousands, except EPS)

Ìý

2025

Ìý

Ìý

Ìý

2024

Ìý

Ìý

Ìý

2025

Ìý

Ìý

Ìý

2024

Ìý

Net Sales

$

374,607

Ìý

Ìý

$

425,036

Ìý

Ìý

$

1,106,255

Ìý

Ìý

$

1,284,352

Ìý

Operating Income

$

11,716

Ìý

Ìý

$

(6,431

)

Ìý

$

29,061

Ìý

Ìý

$

29,669

Ìý

Adjusted Operating Income (non-GAAP) (1)

$

15,706

Ìý

Ìý

$

18,733

Ìý

Ìý

$

41,629

Ìý

Ìý

$

58,802

Ìý

Operating Income %

Ìý

3.1

%

Ìý

Ìý

(1.5

)%

Ìý

Ìý

2.6

%

Ìý

Ìý

2.3

%

Adjusted Operating Income (non-GAAP) %

Ìý

4.2

%

Ìý

Ìý

4.4

%

Ìý

Ìý

3.8

%

Ìý

Ìý

4.6

%

Net Income

$

3,817

Ìý

Ìý

$

(6,076

)

Ìý

$

10,403

Ìý

Ìý

$

12,968

Ìý

Adjusted Net Income (non-GAAP) (1)

$

6,837

Ìý

Ìý

$

9,786

Ìý

Ìý

$

19,718

Ìý

Ìý

$

31,607

Ìý

Diluted EPS

$

0.15

Ìý

Ìý

$

(0.24

)

Ìý

$

0.41

Ìý

Ìý

$

0.51

Ìý

Adjusted Diluted EPS (non-GAAP) (1)

$

0.27

Ìý

Ìý

$

0.39

Ìý

Ìý

$

0.79

Ìý

Ìý

$

1.25

Ìý

(1)

Beginning in the first quarter of fiscal year 2025, adjusted results exclude stock compensation expense. Prior reported periods have been revised accordingly. A reconciliation of GAAP and non-GAAP financial measures is included below.

Commenting on today’s announcement, Richard D. Phillips, Chief Executive Officer, stated, “I’m proud of the results for the third quarter and our team’s ability to navigate an environment of uncertainty, while focusing on what is controllable. Sales in Q3 were in line with expectations, margins improved sequentially, cash generated from operating activities was positive for the fifth consecutive quarter, and the paydown of debt continued with borrowings now 45% lower than peak levels. We have ample liquidity to weather short-term unpredictability and significant dry powder to opportunistically invest in the business.�

Mr. Phillips continued, “As part of today’s release, we are reiterating our guidance for fiscal 2025 with an expectation of sales and operating income at the high-end of the range, as well as, announcing the addition of a new manufacturing facility in Indianapolis focused on the medical industry. This is another step of repositioning the Company for a return to growth and expanding our medical CMO strategy.�

The Company ended the third quarter of fiscal 2025 with cash and cash equivalents of $51.4 million and borrowing capacity available of $253.2 million. Capital expenditures were $4.0 million, and the company invested $3.0 million to repurchase 175,000 shares of common stock.

Net Sales by Vertical Market for Q3 Fiscal 2025:

Ìý

Three Months Ended

Ìý

Ìý

Ìý

Nine Months Ended

Ìý

Ìý

Ìý

March 31,

Ìý

Ìý

Ìý

March 31,

Ìý

Ìý

(Amounts in Millions)

Ìý

2025

Ìý

*

Ìý

Ìý

2024

Ìý

*

Ìý

Percent

Change

Ìý

Ìý

2025

Ìý

*

Ìý

Ìý

2024

Ìý

*

Ìý

Percent Change

Automotive

$

173.1

Ìý

46

%

Ìý

$

202.0

Ìý

47

%

Ìý

(14

)%

Ìý

$

554.3

Ìý

50

%

Ìý

$

614.7

Ìý

48

%

Ìý

(10

)%

Medical

Ìý

115.2

Ìý

31

%

Ìý

Ìý

113.0

Ìý

27

%

Ìý

2

%

Ìý

Ìý

288.9

Ìý

26

%

Ìý

Ìý

323.5

Ìý

25

%

Ìý

(11

)%

Industrial excluding AT&M (1)

Ìý

86.3

Ìý

23

%

Ìý

Ìý

101.9

Ìý

24

%

Ìý

(15

)%

Ìý

Ìý

261.0

Ìý

24

%

Ìý

Ìý

315.3

Ìý

25

%

Ìý

(17

)%

Net Sales excluding AT&M (1)

$

374.6

Ìý

100

%

$

416.9

Ìý

98

%

Ìý

(10

)%

Ìý

$

1,104.2

Ìý

100

%

Ìý

$

1,253.5

Ìý

98

%

Ìý

(12

)%

AT&M (1)

Ìý

�

Ìý

�

%

Ìý

Ìý

8.1

Ìý

2

%

Ìý

(100

)%

Ìý

Ìý

2.1

Ìý

�

%

Ìý

Ìý

30.9

Ìý

2

%

Ìý

(93

)%

Total Net Sales

$

374.6

Ìý

100

%

Ìý

$

425.0

Ìý

100

%

Ìý

(12

)%

Ìý

$

1,106.3

Ìý

100

%

Ìý

$

1,284.4

Ìý

100

%

Ìý

(14

)%

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

* As a percent of Total Net Sales

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

(1) Sales from our Automation, Test, and Measurement business (AT&M), which was divested effective July 31, 2024, were previously included in the Industrial vertical

� Automotive includes electronic power steering, body controls, automated driver assist systems, and electronic braking systems

� Medical includes sleep therapy and respiratory care, image guided therapy, in vitro diagnostics, drug delivery, AED, and patient monitoring

� Industrial includes climate controls, automation controls, and public safety

Company Guidance for Fiscal Year 2025

The Company expects to be at the high-end of its guidance range for both net sales and adjusted operating income. The range for net sales is $1.40 - $1.44 billion, while the range for adjusted operating income(a) is 3.4% - 3.6% of net sales. Capital expenditures are estimated to be at the low-end of the guidance range of $40 - $50 million.

(a)

Fiscal year 2025 guidance reflects a change in our adjusted operating income calculation beginning in fiscal year 2025, which excludes stock compensation expense. This change better aligns our presentation with others in our industry. A reconciliation of GAAP and non-GAAP financial measures is included below.

Forward-Looking Statements

Certain statements contained within this release are considered forward-looking, including our guidance, under the Private Securities Litigation Reform Act of 1995. The statements may be identified by the use of words such as “expect,� “should,� “goal,� “predict,� “will,� “future,� “optimistic,� “confident,� and “believe.� Undue reliance should not be placed on these forward-looking statements. These statements are based on current expectations of future events and thus are inherently subject to uncertainty. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from our expectations and projections. These forward-looking statements are subject to risks and uncertainties including, without limitation, global economic conditions, geopolitical environment and conflicts such as the war in Ukraine, global health emergencies, availability or cost of raw materials and components, tariffs and other trade barriers, foreign exchange rate fluctuations, and our ability to convert new business opportunities into customers and revenue. Additional cautionary statements regarding other risk factors that could have an effect on the future performance of the company are contained in its Annual Report on Form 10-K for the year ended June 30, 2024.

Non-GAAP Financial Measures

This press release contains non-GAAP financial measures. The non-GAAP financial measures contained herein include constant currency growth, net sales excluding Automation, Test & Measurement, adjusted selling and administrative expenses, adjusted operating income, adjusted net income, adjusted diluted EPS, and ROIC. Reconciliations of the reported GAAP numbers to these non-GAAP financial measures are included in the Reconciliation of Non-GAAP Financial Measures section below. Management believes these measures are useful and allow investors to meaningfully trend, analyze, and benchmark the performance of the company’s core operations. The company’s non-GAAP financial measures are not necessarily comparable to non-GAAP information used by other companies.

About Kimball Electronics, Inc.

Kimball Electronics is a global, multifaceted manufacturer offering Electronics Manufacturing Services (EMS) and Contract Manufacturing Organization (CMO) solutions to customers around the world. From our operations in the United States, China, Mexico, Poland, Romania, and Thailand, our teams are proud to provide manufacturing services for a variety of industries. Recognized for a reputation of excellence, we are committed to a high-performance culture that values quality, reliability, value, speed, and ethical behavior. Kimball Electronics, Inc. (Nasdaq: KE) is headquartered in Jasper, Indiana.

To learn more about Kimball Electronics, visit .

Conference Call / Webcast

Ìý

Ìý

Ìý

Ìý

Ìý

Date:

Ìý

May 7, 2025

Ìý

Time:

Ìý

10:00 AM Eastern Time

Ìý

Live Webcast:

Ìý

investors.kimballelectronics.com/events-and-presentations/events

Ìý

Dial-In #:

Ìý

877-407-8293 (or 201-689-8349)

Ìý

Ìý

Ìý

Ìý

Ìý

For those unable to participate in the live webcast, the call will be archived at investors.kimballelectronics.com.

Lasting relationships. Global success.

Financial highlights for the third quarter and year-to-date period ended March 31, 2025 are as follows:

Condensed Consolidated Statements of Income

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

(Unaudited)

Three Months Ended

(Amounts in Thousands, except Per Share Data)

March 31, 2025

Ìý

March 31, 2024

Net Sales

$

374,607

Ìý

Ìý

100.0

%

Ìý

$

425,036

Ìý

Ìý

100.0

%

Cost of Sales

Ìý

347,711

Ìý

Ìý

92.8

%

Ìý

Ìý

391,492

Ìý

Ìý

92.1

%

Gross Profit

Ìý

26,896

Ìý

Ìý

7.2

%

Ìý

Ìý

33,544

Ìý

Ìý

7.9

%

Selling and Administrative Expenses

Ìý

13,154

Ìý

Ìý

3.6

%

Ìý

Ìý

16,861

Ìý

Ìý

3.9

%

Other General Expense (Income)

Ìý

�

Ìý

Ìý

�

%

Ìý

Ìý

(892

)

Ìý

(0.2

)%

Restructuring Expense

Ìý

2,026

Ìý

Ìý

0.5

%

Ìý

Ìý

1,622

Ìý

Ìý

0.4

%

Goodwill Impairment

Ìý

�

Ìý

Ìý

�

%

Ìý

Ìý

5,820

Ìý

Ìý

1.4

%

Asset Impairment (Gain on Disposal)

Ìý

�

Ìý

Ìý

�

%

Ìý

Ìý

16,564

Ìý

Ìý

3.9

%

Operating Income

Ìý

11,716

Ìý

Ìý

3.1

%

Ìý

Ìý

(6,431

)

Ìý

(1.5

)%

Interest Income

Ìý

100

Ìý

Ìý

�

%

Ìý

Ìý

83

Ìý

Ìý

�

%

Interest Expense

Ìý

(2,936

)

Ìý

(0.8

)%

Ìý

Ìý

(5,875

)

Ìý

(1.4

)%

Non-Operating Income (Expense), net

Ìý

(1,726

)

Ìý

(0.4

)%

Ìý

Ìý

(530

)

Ìý

(0.1

)%

Other Income (Expense), net

Ìý

(4,562

)

Ìý

(1.2

)%

Ìý

Ìý

(6,322

)

Ìý

(1.5

)%

Income Before Taxes on Income

Ìý

7,154

Ìý

Ìý

1.9

%

Ìý

Ìý

(12,753

)

Ìý

(3.0

)%

Provision (Benefit) for Income Taxes

Ìý

3,337

Ìý

Ìý

0.9

%

Ìý

Ìý

(6,677

)

Ìý

(1.6

)%

Net Income (Loss)

$

3,817

Ìý

Ìý

1.0

%

Ìý

$

(6,076

)

Ìý

(1.4

)%

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Earnings Per Share of Common Stock:

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Basic

$

0.15

Ìý

Ìý

Ìý

Ìý

$

(0.24

)

Ìý

Ìý

Diluted

$

0.15

Ìý

Ìý

Ìý

Ìý

$

(0.24

)

Ìý

Ìý

Average Number of Shares Outstanding:

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Basic

Ìý

24,728

Ìý

Ìý

Ìý

Ìý

Ìý

25,118

Ìý

Ìý

Ìý

Diluted

Ìý

24,872

Ìý

Ìý

Ìý

Ìý

Ìý

25,118

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

(Unaudited)

Nine Months Ended

(Amounts in Thousands, except Per Share Data)

March 31, 2025

Ìý

March 31, 2024

Net Sales

$

1,106,255

Ìý

Ìý

100.0

%

Ìý

$

1,284,352

Ìý

Ìý

100.0

%

Cost of Sales

Ìý

1,032,332

Ìý

Ìý

93.3

%

Ìý

Ìý

1,180,833

Ìý

Ìý

91.9

%

Gross Profit

Ìý

73,923

Ìý

Ìý

6.7

%

Ìý

Ìý

103,519

Ìý

Ìý

8.1

%

Selling and Administrative Expenses

Ìý

37,107

Ìý

Ìý

3.4

%

Ìý

Ìý

50,736

Ìý

Ìý

4.0

%

Other General Expense (Income)

Ìý

�

Ìý

Ìý

�

%

Ìý

Ìý

(892

)

Ìý

(0.1

)%

Restructuring Expense

Ìý

9,019

Ìý

Ìý

0.8

%

Ìý

Ìý

1,622

Ìý

Ìý

0.1

%

Goodwill Impairment

Ìý

�

Ìý

Ìý

�

%

Ìý

Ìý

5,820

Ìý

Ìý

0.5

%

Asset Impairment (Gain on Disposal)

Ìý

(1,264

)

Ìý

(0.1

)%

Ìý

Ìý

16,564

Ìý

Ìý

1.3

%

Operating Income

Ìý

29,061

Ìý

Ìý

2.6

%

Ìý

Ìý

29,669

Ìý

Ìý

2.3

%

Interest Income

Ìý

575

Ìý

Ìý

0.1

%

Ìý

Ìý

483

Ìý

Ìý

�

%

Interest Expense

Ìý

(11,969

)

Ìý

(1.1

)%

Ìý

Ìý

(17,459

)

Ìý

(1.4

)%

Non-Operating Income (Expense), net

Ìý

(4,155

)

Ìý

(0.4

)%

Ìý

Ìý

(959

)

Ìý

�

%

Other Income (Expense), net

Ìý

(15,549

)

Ìý

(1.4

)%

Ìý

Ìý

(17,935

)

Ìý

(1.4

)%

Income Before Taxes on Income

Ìý

13,512

Ìý

Ìý

1.2

%

Ìý

Ìý

11,734

Ìý

Ìý

0.9

%

Provision (Benefit) for Income Taxes

Ìý

3,109

Ìý

Ìý

0.3

%

Ìý

Ìý

(1,234

)

Ìý

(0.1

)%

Net Income

$

10,403

Ìý

Ìý

0.9

%

Ìý

$

12,968

Ìý

Ìý

1.0

%

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Earnings Per Share of Common Stock:

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Basic

$

0.42

Ìý

Ìý

Ìý

Ìý

$

0.52

Ìý

Ìý

Ìý

Diluted

$

0.41

Ìý

Ìý

Ìý

Ìý

$

0.51

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Average Number of Shares Outstanding:

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Basic

Ìý

24,859

Ìý

Ìý

Ìý

Ìý

Ìý

25,084

Ìý

Ìý

Ìý

Diluted

Ìý

25,047

Ìý

Ìý

Ìý

Ìý

Ìý

25,263

Ìý

Ìý

Ìý

Condensed Consolidated Statements of Cash Flows

Nine Months Ended

(Unaudited)

March 31,

(Amounts in Thousands)

Ìý

2025

Ìý

Ìý

Ìý

2024

Ìý

Net Cash Flow provided by Operating Activities

$

105,870

Ìý

Ìý

$

24,717

Ìý

Net Cash Flow used for Investing Activities

Ìý

(5,160

)

Ìý

Ìý

(37,702

)

Net Cash Flow (used for) provided by Financing Activities

Ìý

(126,615

)

Ìý

Ìý

36,571

Ìý

Effect of Exchange Rate Change on Cash, Cash Equivalents, and Restricted Cash

Ìý

13

Ìý

Ìý

Ìý

(113

)

Net (Decrease) Increase in Cash, Cash Equivalents, and Restricted Cash

Ìý

(25,892

)

Ìý

Ìý

23,473

Ìý

Cash, Cash Equivalents, and Restricted Cash at Beginning of Period

Ìý

78,779

Ìý

Ìý

Ìý

43,864

Ìý

Cash, Cash Equivalents, and Restricted Cash at End of Period

$

52,887

Ìý

Ìý

$

67,337

Ìý

(Unaudited)

Ìý

Ìý

Condensed Consolidated Balance Sheets

March 31,
2025

Ìý

June 30,
2024

(Amounts in Thousands)

ASSETS

Ìý

Ìý

Ìý

Cash and cash equivalents

$

51,377

Ìý

$

77,965

Receivables, net

Ìý

251,138

Ìý

Ìý

282,336

Contract assets

Ìý

78,378

Ìý

Ìý

76,320

Inventories

Ìý

296,602

Ìý

Ìý

338,116

Prepaid expenses and other current assets

Ìý

29,808

Ìý

Ìý

44,682

Assets held for sale

Ìý

�

Ìý

Ìý

27,587

Property and Equipment, net

Ìý

268,351

Ìý

Ìý

269,659

Goodwill

Ìý

6,191

Ìý

Ìý

6,191

Other Intangible Assets, net

Ìý

2,601

Ìý

Ìý

2,994

Other Assets, net

Ìý

90,109

Ìý

Ìý

82,069

Total Assets

$

1,074,555

Ìý

$

1,207,919

Ìý

Ìý

Ìý

Ìý

LIABILITIES AND SHARE OWNERS� EQUITY

Ìý

Ìý

Ìý

Current portion of long-term debt

$

28,900

Ìý

$

59,837

Accounts payable

Ìý

215,430

Ìý

Ìý

213,551

Advances from customers

Ìý

39,676

Ìý

Ìý

30,151

Accrued expenses

Ìý

46,951

Ìý

Ìý

63,189

Liabilities held for sale

Ìý

�

Ìý

Ìý

8,594

Long-term debt, less current portion

Ìý

149,376

Ìý

Ìý

235,000

Long-term income taxes payable

Ìý

�

Ìý

Ìý

3,255

Other long-term liabilities

Ìý

46,107

Ìý

Ìý

53,881

Share Owners� Equity

Ìý

548,115

Ìý

Ìý

540,461

Total Liabilities and Share Owners� Equity

$

1,074,555

Ìý

$

1,207,919

Other Financial Metrics

Ìý

Ìý

Ìý

Ìý

(Unaudited)

Ìý

Ìý

Ìý

Ìý

Ìý

(Amounts in Millions, except CCD)

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

At or For the

Ìý

Three Months Ended

Ìý

March 31,

Ìý

December 31,

Ìý

March 31,

Ìý

Ìý

2025

Ìý

Ìý

2024

Ìý

Ìý

2024

Depreciation and Amortization

$

9.2

Ìý

$

9.1

Ìý

$

10.5

Cash Conversion Days (CCD) (1)

Ìý

99

Ìý

Ìý

107

Ìý

Ìý

110

Open Orders (2)

$

642

Ìý

$

564

Ìý

$

831

(1)

Cash Conversion Days (“CCD�) are calculated as the sum of Days Sales Outstanding plus Contract Asset Days plus Production Days Supply on Hand less Accounts Payable Days and less Advances from Customers Days. CCD, or a similar metric, is used in our industry and by our management to measure the efficiency of managing working capital.

(2)

Open Orders are the aggregate sales price of production pursuant to unfulfilled customer orders. Our declining open orders are primarily due to the cancellation of a major automotive program and other demand reductions, as well as reduced lead times on customer orders as compared to March 31, 2024, when parts were more constrained.

Select Financial Results of Automation, Test and Measurement

Ìý

Ìý

Ìý

Ìý

(Unaudited)

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

(Amounts in Millions)

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Three Months Ended

Ìý

Nine Months Ended

Ìý

March 31,

Ìý

March 31,

Ìý

Ìý

2025

Ìý

Ìý

2024

Ìý

Ìý

Ìý

2025

Ìý

Ìý

2024

Ìý

Net Sales

$

�

Ìý

$

8.1

Ìý

Ìý

$

2.1

Ìý

$

30.9

Ìý

Operating Income (Loss) (1)

$

�

Ìý

$

(25.4

)

Ìý

$

0.8

Ìý

$

(24.3

)

(1)

Includes gain on sale of $1.3 million following the close of the sale on July 31, 2024 for the nine months ended March 31, 2025. Includes goodwill impairment of $5.8 million and asset impairment of $16.6 million for the three and nine months ended March 31, 2024. Each period also includes allocated corporate overhead expenses.

Reconciliation of Non-GAAP Financial Measures

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

(Unaudited, Amounts in Thousands, except Per Share Data)

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Three Months Ended

Ìý

Nine Months Ended

Ìý

March 31,

Ìý

March 31,

Ìý

Ìý

2025

Ìý

Ìý

Ìý

2024

Ìý

Ìý

Ìý

2025

Ìý

Ìý

Ìý

2024

Ìý

Net Sales Growth (vs. same period in prior year)

Ìý

(12

)%

Ìý

Ìý

(12

)%

Ìý

Ìý

(14

)%

Ìý

Ìý

(3

)%

Foreign Currency Exchange Impact

Ìý

(1

)%

Ìý

Ìý

�

%

Ìý

Ìý

�

%

Ìý

Ìý

�

%

Constant Currency Growth

Ìý

(11

)%

Ìý

Ìý

(12

)%

Ìý

Ìý

(14

)%

Ìý

Ìý

(3

)%

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Selling and Administrative Expenses, as reported

$

13,154

Ìý

Ìý

$

16,861

Ìý

Ìý

$

37,107

Ìý

Ìý

$

50,736

Ìý

Stock Compensation Expense

Ìý

(1,955

)

Ìý

Ìý

(1,773

)

Ìý

Ìý

(4,528

)

Ìý

Ìý

(5,435

)

SERP

Ìý

(9

)

Ìý

Ìý

(277

)

Ìý

Ìý

(285

)

Ìý

Ìý

(584

)

Adjusted Selling and Administrative Expenses

$

11,190

Ìý

Ìý

$

14,811

Ìý

Ìý

$

32,294

Ìý

Ìý

$

44,717

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Operating Income (Loss), as reported

$

11,716

Ìý

Ìý

$

(6,431

)

Ìý

$

29,061

Ìý

Ìý

$

29,669

Ìý

Stock Compensation Expense

Ìý

1,955

Ìý

Ìý

Ìý

1,773

Ìý

Ìý

Ìý

4,528

Ìý

Ìý

Ìý

5,435

Ìý

SERP

Ìý

9

Ìý

Ìý

Ìý

277

Ìý

Ìý

Ìý

285

Ìý

Ìý

Ìý

584

Ìý

Legal Settlements (Recovery)

Ìý

�

Ìý

Ìý

Ìý

(892

)

Ìý

Ìý

�

Ìý

Ìý

Ìý

(892

)

Restructuring Expense

Ìý

2,026

Ìý

Ìý

Ìý

1,622

Ìý

Ìý

Ìý

9,019

Ìý

Ìý

Ìý

1,622

Ìý

Goodwill Impairment

Ìý

�

Ìý

Ìý

Ìý

5,820

Ìý

Ìý

Ìý

�

Ìý

Ìý

Ìý

5,820

Ìý

Asset Impairment (Gain on Disposal)

Ìý

�

Ìý

Ìý

Ìý

16,564

Ìý

Ìý

Ìý

(1,264

)

Ìý

Ìý

16,564

Ìý

Adjusted Operating Income

$

15,706

Ìý

Ìý

$

18,733

Ìý

Ìý

$

41,629

Ìý

Ìý

$

58,802

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Net Income (Loss), as reported

$

3,817

Ìý

Ìý

$

(6,076

)

Ìý

$

10,403

Ìý

Ìý

$

12,968

Ìý

Stock Compensation Expense, After-Tax

Ìý

1,483

Ìý

Ìý

Ìý

1,345

Ìý

Ìý

Ìý

3,434

Ìý

Ìý

Ìý

4,122

Ìý

Legal Settlements (Recovery), After-Tax

Ìý

�

Ìý

Ìý

Ìý

(676

)

Ìý

Ìý

�

Ìý

Ìý

Ìý

(676

)

Restructuring Expense, After-Tax

Ìý

1,537

Ìý

Ìý

Ìý

1,230

Ìý

Ìý

Ìý

6,840

Ìý

Ìý

Ìý

1,230

Ìý

Goodwill Impairment, After-Tax

Ìý

�

Ìý

Ìý

Ìý

4,414

Ìý

Ìý

Ìý

�

Ìý

Ìý

Ìý

4,414

Ìý

Asset Impairment (Gain on Disposal), After-Tax

Ìý

�

Ìý

Ìý

Ìý

9,549

Ìý

Ìý

Ìý

(959

)

Ìý

Ìý

9,549

Ìý

Adjusted Net Income

$

6,837

Ìý

Ìý

$

9,786

Ìý

Ìý

$

19,718

Ìý

Ìý

$

31,607

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Diluted Earnings per Share, as reported

$

0.15

Ìý

Ìý

$

(0.24

)

Ìý

$

0.41

Ìý

Ìý

$

0.51

Ìý

Stock Compensation Expense

Ìý

0.06

Ìý

Ìý

Ìý

0.05

Ìý

Ìý

Ìý

0.14

Ìý

Ìý

Ìý

0.16

Ìý

Legal Settlements (Recovery)

Ìý

�

Ìý

Ìý

Ìý

(0.03

)

Ìý

Ìý

�

Ìý

Ìý

Ìý

(0.03

)

Restructuring Expense

Ìý

0.06

Ìý

Ìý

Ìý

0.05

Ìý

Ìý

Ìý

0.27

Ìý

Ìý

Ìý

0.05

Ìý

Goodwill Impairment

Ìý

�

Ìý

Ìý

Ìý

0.18

Ìý

Ìý

Ìý

�

Ìý

Ìý

Ìý

0.18

Ìý

Asset Impairment (Gain on Disposal)

Ìý

�

Ìý

Ìý

Ìý

0.38

Ìý

Ìý

Ìý

(0.03

)

Ìý

Ìý

0.38

Ìý

Adjusted Diluted Earnings per Share

$

0.27

Ìý

Ìý

$

0.39

Ìý

Ìý

$

0.79

Ìý

Ìý

$

1.25

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Twelve Months Ended

Ìý

Ìý

Ìý

Ìý

Ìý

March 31,

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

2025

Ìý

Ìý

Ìý

2024

Ìý

Ìý

Ìý

Ìý

Ìý

Operating Income

$

48,669

Ìý

Ìý

$

61,118

Ìý

Ìý

Ìý

Ìý

Ìý

Goodwill Impairment

Ìý

�

Ìý

Ìý

Ìý

5,820

Ìý

Ìý

Ìý

Ìý

Ìý

SERP

Ìý

381

Ìý

Ìý

Ìý

827

Ìý

Ìý

Ìý

Ìý

Ìý

Restructuring Expense

Ìý

9,783

Ìý

Ìý

Ìý

1,622

Ìý

Ìý

Ìý

Ìý

Ìý

Asset Impairment (Gain on Disposal)

Ìý

(788

)

Ìý

Ìý

16,564

Ìý

Ìý

Ìý

Ìý

Ìý

Legal Settlements (Recovery)

Ìý

�

Ìý

Ìý

Ìý

(1,104

)

Ìý

Ìý

Ìý

Ìý

Stock Compensation Expense

Ìý

6,278

Ìý

Ìý

Ìý

6,992

Ìý

Ìý

Ìý

Ìý

Ìý

Adjusted Operating Income (non-GAAP)

$

64,323

Ìý

Ìý

$

91,839

Ìý

Ìý

Ìý

Ìý

Ìý

Tax Effect

Ìý

20,174

Ìý

Ìý

Ìý

21,698

Ìý

Ìý

Ìý

Ìý

Ìý

After-tax Adjusted Operating Income

$

44,149

Ìý

Ìý

$

70,141

Ìý

Ìý

Ìý

Ìý

Ìý

Average Invested Capital (1)

$

726,208

Ìý

Ìý

$

783,059

Ìý

Ìý

Ìý

Ìý

Ìý

ROIC

Ìý

6.1

%

Ìý

Ìý

9.0

%

Ìý

Ìý

Ìý

Ìý

(1)

Average invested capital is computed using Share Owners� equity plus current and non-current debt less cash and cash equivalents averaged for the last five quarters.

Ìý

Andrew D. Regrut

Treasurer and Investor Relations Officer

812.827.4151

[email protected]

Source: Kimball Electronics, Inc.

Kimball Electronics Inc

NASDAQ:KE

KE Rankings

KE Latest News

KE Latest SEC Filings

KE Stock Data

481.27M
23.84M
2.04%
79.2%
1.47%
Electrical Equipment & Parts
Printed Circuit Boards
United States
JASPER